GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » ROE % Adjusted to Book Value

Yidu Tech (HKSE:02158) ROE % Adjusted to Book Value : -3.80% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech ROE % Adjusted to Book Value?

Yidu Tech's ROE % for the quarter that ended in Sep. 2023 was -3.57%. Yidu Tech's PB Ratio for the quarter that ended in Sep. 2023 was 0.94. Yidu Tech's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was -3.80%.

Yidu Tech ROE % Adjusted to Book Value Historical Data

The historical data trend for Yidu Tech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yidu Tech ROE % Adjusted to Book Value Chart

Yidu Tech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - -99.77 -9.08 -9.17

Yidu Tech Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.05 -7.96 -15.79 -8.36 -3.80

Competitive Comparison of Yidu Tech's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Yidu Tech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yidu Tech's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Yidu Tech's ROE % Adjusted to Book Value falls into.


Yidu Tech ROE % Adjusted to Book Value Calculation

Yidu Tech's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-14.95% / 1.63
=-9.17%

Yidu Tech's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-3.57% / 0.94
=-3.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yidu Tech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Yidu Tech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Yidu Tech (HKSE:02158) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:09886 HKSE:02415 HKSE:02361 HKSE:06819 HKSE:09686 HKSE:02251 HKSE:02159 HKSE:01833 GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC EVH PRVA
Traded in Other Exchanges
0EL:Germany
Address
No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN
Website
https://www.yidutechgroup.com
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Executives
Gong Yingying 2202 Interest of your spouse
Xu Jiming 2101 Beneficial owner
Brunei Investment Agency 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
Sweet Panda Limited 2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines